MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-26-2026
Thermo Fisher Scientific ROCE Ratio 2011-2026 | TMO
Annual ROCE Ratio Thermo Fisher Scientific
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.5 | 14.8 | 14.68 | 19.06 | 24.55 | 22.58 | 8.01 | 7.65 | 6.18 | 6.43 | 6.67 | 5.08 | 5.87 | 6.17 | 5.67 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 24.55 | 5.08 | 11.19 |
Quarterly ROCE Ratio Thermo Fisher Scientific
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.66 | 14.7 | 14.72 | 15.36 | 15.21 | 15.06 | 15.33 | 15.14 | 16.26 | 15.52 | 21.4 | 23.36 | 24.5 | 20.44 | 27.47 | 28.63 | 26.79 | 13.69 | 16.87 | 13.03 | 14.04 | 11.33 | 14.64 | 14.75 | 13.11 | 9.55 | 12.05 | 11.24 | 10.79 | 7.88 | 10.39 | 10.41 | 10.42 | 7.88 | 10.51 | 10.64 | 10.47 | 7.71 | 10.83 | 11.31 | 10.21 | 9.07 | 11.4 | 10.61 | 11.14 | 6.85 | 9.13 | 9.08 | 9.23 | 6.99 | 9.09 | 8.92 | 8.3 | 6.0 | 2.1 | 1.76 | 2.14 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 28.63 | 1.76 | 12.63 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
25.0 | $ 114.84 | -0.55 % | $ 34.9 B |  USA |
 |
Aspira Women's Health
AWH
|
114.15 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1809.55 | - | - | $ 9.42 M |  Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
 |
CareDx, Inc
CDNA
|
-10.16 | $ 17.82 | -2.68 % | $ 950 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
-41.81 | $ 16.3 | 0.62 % | $ 175 M |  China |
 |
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | China |
 |
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
|
Biodesix
BDSX
|
-41.6 | $ 15.36 | 1.92 % | $ 1.99 B | USA |
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | USA |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
QIAGEN N.V.
QGEN
|
8.07 | - | - | $ 10.6 B |  Niderland |
 |
Co-Diagnostics
CODX
|
-236.6 | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
Anixa Biosciences
ANIX
|
-77.18 | $ 2.59 | 1.57 % | $ 84.1 K | USA |
 |
Biomerica
BMRA
|
-125.14 | $ 2.17 | - | $ 4.98 M | USA |
 |
BioNano Genomics
BNGO
|
-75.05 | $ 1.15 | -4.17 % | $ 6.26 M | USA |
 |
Charles River Laboratories International
CRL
|
0.8 | $ 168.22 | -3.26 % | $ 8.34 B | USA |
 |
Castle Biosciences
CSTL
|
1.9 | $ 24.73 | -0.44 % | $ 687 M | USA |
 |
Danaher Corporation
DHR
|
8.93 | $ 192.12 | 0.52 % | $ 137 B | USA |
 |
Celcuity
CELC
|
-171.24 | $ 114.22 | 1.41 % | $ 5.34 B | USA |
 |
DexCom
DXCM
|
33.2 | $ 63.21 | 1.59 % | $ 24.7 B | USA |
 |
Fulgent Genetics
FLGT
|
-6.52 | $ 16.42 | -2.38 % | $ 496 M | USA |
 |
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | USA |
 |
Guardant Health
GH
|
440.3 | $ 89.66 | -4.44 % | $ 11.2 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 198.96 | 0.91 % | $ 22.1 B | USA |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | Israel |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 109.62 | -4.0 % | $ 9.04 B |  Irlanda |
 |
Illumina
ILMN
|
-35.1 | $ 127.74 | 0.28 % | $ 20.3 B | USA |
 |
IQVIA Holdings
IQV
|
33.55 | $ 170.72 | -1.47 % | $ 29.3 B | USA |
 |
Interpace Biosciences
IDXG
|
18.26 | $ 1.97 | 0.63 % | $ 8.72 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 274.46 | 0.27 % | $ 22.8 B | USA |
 |
Lantheus Holdings
LNTH
|
28.52 | $ 75.89 | -0.28 % | $ 5.12 B | USA |
 |
Medpace Holdings
MEDP
|
116.53 | $ 496.0 | -0.47 % | $ 14.3 B | USA |
 |
Invitae Corporation
NVTA
|
-93.18 | - | - | $ 21.2 M | USA |
 |
Mettler-Toledo International
MTD
|
35.8 | $ 1 266.63 | 0.53 % | $ 26.1 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
-105.22 | $ 4.67 | -1.68 % | $ 432 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-185.74 | $ 4.74 | 1.07 % | $ 3.73 M | USA |
 |
NeoGenomics
NEO
|
-9.11 | $ 8.02 | 0.25 % | $ 1.03 B | USA |
 |
Neogen Corporation
NEOG
|
-51.22 | $ 9.56 | 1.59 % | $ 2.07 B | USA |
 |
National Research Corporation
NRC
|
161.47 | $ 17.33 | 0.99 % | $ 388 M | USA |